Related Experiment Video
Updated: Jul 5, 2025
06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
10.5K
Metabolism in Hematopoiesis and Its Malignancy
Xiaoyuan Zeng1, Yi-Ping Wang2, Cheuk-Him Man3
1Division of Haematology, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Advances in Experimental Medicine and Biology
|January 16, 2024
Summary
Hematopoietic stem cells (HSCs) maintain blood cell production. Their metabolism is crucial for function and can be targeted for treating blood cancers by exploiting unique metabolic dependencies in malignant cells.
Area of Science:
- Hematology
- Cell Biology
- Metabolic Regulation
Background:
- Hematopoietic stem cells (HSCs) are vital for continuous blood cell generation and maintaining homeostasis.
- Cell metabolism critically influences HSC function, including epigenetic modifications and cell cycle control.
- Malignant transformation in hematopoietic cells hijacks metabolic pathways to fuel uncontrolled growth.
Purpose of the Study:
- To explore the role of metabolic pathways in normal hematopoiesis.
- To investigate the distinct metabolic dependencies in hematopoietic malignancies.
- To discuss the potential of metabolism-targeted therapies for blood cancers.
Main Methods:
- Review of current literature on HSC metabolism.
- Analysis of metabolic reprogramming in hematopoietic cancers.
- Discussion of therapeutic strategies targeting cancer metabolism.
Main Results:
- Metabolic pathways are essential regulators of HSC function and maintenance.
- Hematopoietic malignancies exhibit unique metabolic vulnerabilities.
- Metabolic dysregulation contributes to oncogene addiction in cancer cells.
Conclusions:
- Understanding HSC metabolism is key to comprehending blood cell development and disease.
- Targeting specific metabolic pathways in malignant hematopoietic cells offers a promising therapeutic avenue.
- Metabolism-targeted therapies represent a novel strategy for treating blood cancers.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
01:28Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
01:20Overview of Hematopoiesis
4.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.0K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
01:21Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K